In addition, previous research revealed overexpression of YKL-40 in serum and/or lung samples in patients with IPF (27–30) and the regulatory role of YKL-40 in the development and progression of pulmonary fibrosis (31). The gene discussed is CHI3L1; the disease is pulmonary fibrosis.